ÂÜÀòÂÒÂ×

Christian Anker-Ladefoged is an investment professional with extensive experience in venture capital, particularly within the LifeScience sector, encompassing HealthTech, MedTech, and BioTech. Currently serving as an Investor and Board Member at WARD 24/7 and an Investor and Board Observer at Pephexia Therapeutics ApS, Christian has held various roles in investment and advisory capacities with multiple organizations, including Denmark’s Export and Investment Fund as a Senior Investment Associate, where responsibilities included leading investments in emerging companies. Christian's previous experience includes financial analysis at VELUX and an innovation consultancy internship in South Korea. Academic credentials include a Master of Science in Finance and Strategic Management and a Bachelor of Science in International Business from Copenhagen Business School, along with exchange programs at Yonsei University and Arizona State University's W. P. Carey School of Business.